GSE219154 aspirin 4 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE219154_aspirin_4_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE219154_aspirin_4_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE219154_aspirin_4_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE219154_aspirin_4_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 1873

Gene

RNF32 antisense RNA 1

Gene

DEAD-box helicase 10 pseudogene 1

Gene

DPYD antisense RNA 1

Gene

ribosomal protein L27a pseudogene 5

Gene

family with sequence similarity 90 member A20

Gene

ribosomal protein L36a pseudogene 29

Gene

olfactory receptor family 52 subfamily T member 1 pseudogene

Gene

microRNA 4480

Gene

RNA, variant U1 small nuclear 33

  • Gene

    long intergenic non-protein coding RNA 1873


  • Gene

    RNF32 antisense RNA 1


  • Gene

    DEAD-box helicase 10 pseudogene 1


  • Gene

    DPYD antisense RNA 1


  • Gene

    ribosomal protein L27a pseudogene 5


  • Gene

    family with sequence similarity 90 member A20


  • Gene

    ribosomal protein L36a pseudogene 29


  • Gene

    olfactory receptor family 52 subfamily T member 1 pseudogene



  • Gene

    RNA, variant U1 small nuclear 33

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.